-
361
Effect of a high dose atorvastatin as adjuvant therapy to mesalamine in attenuating inflammation and symptoms in patients with ulcerative colitis: a randomized controlled pilot stu...
Published 2025-01-01“…BackgroundUlcerative colitis (UC) is a chronic inflammatory disorder of the colon. Several preclinical studies investigated the beneficial effects of atorvastatin in colitis. …”
Get full text
Article -
362
Comparative analysis of retinal vascular structural parameters in populations with different glucose metabolism status based on color fundus photography and artificial intelligence
Published 2025-02-01“…These parameters hold promise as preclinical biomarkers for detecting vascular abnormalities associated with DR.…”
Get full text
Article -
363
Development and characterization of orthotopic patient-derived xenograft models of peritoneal metastatic mucinous appendiceal adenocarcinoma
Published 2025-03-01“…Background: Appendiceal adenocarcinomas (AAs) are a rare and heterogeneous group of tumors for which few preclinical models exist. The lack of preclinical models of AA has hindered drug development and is a major factor in why AA remains without a single Food and Drug Administration-approved systemic treatment. …”
Get full text
Article -
364
Enhancement of anti‐sarcoma immunity by NK cells engineered with mRNA for expression of a EphA2‐targeted CAR
Published 2025-01-01“…The findings establish a strong preclinical rationale for the clinical evaluation of EphA2‐targeted CAR‐NK therapy as a novel immunotherapeutic option for paediatric sarcomas. …”
Get full text
Article -
365
The Role and the Regulation of NLRP3 Inflammasome in Irritable Bowel Syndrome: A Narrative Review
Published 2025-01-01“…NLRP3 inflammasome is part of the nucleotide-binding oligomerization domain-like receptor (NLR) family, a crucial component of the innate immune system. Preclinical studies have demonstrated that inhibiting NLRP3 reduces visceral sensitivity and IBS symptoms, like abdominal pain, and diarrhea, suggesting that targeting the NLRP3 might represent a novel therapeutic approach for IBS. …”
Get full text
Article -
366
Natural Products for Cancer Therapy: A Review of Their Mechanism of Actions and Toxicity in the Past Decade
Published 2022-01-01“…This review can provide valuable insights for researchers in developing methods, strategies during preclinical and clinical evaluation of anticancer candidates.…”
Get full text
Article -
367
Herbal and tuberculosis in Indonesia: Bibliometric analysis
Published 2025-01-01“…Keyword co-occurrence analysis identified “mycobacterium tuberculosis,” “animal experiment,” and “plant extract” as central themes, highlighting a predominant focus on preclinical research and the chemical analysis of plant-based treatments.…”
Get full text
Article -
368
Epidural Fat and Perineural Adipose Tissue Septic Emboli Mimicking Peripheral Nerve Sheath Tumor in a Dog
Published 2022-01-01Get full text
Article -
369
Effects of (±) 3,4-Methylenedioxymethamphetamine (MDMA) on Sleep and Circadian Rhythms
Published 2007-01-01“…This paper will review preclinical and clinical studies that have explored the effects of prior MDMA exposure on sleep, circadian activity, and the circadian pacemaker, and will highlight current gaps in knowledge and suggest areas for future research.…”
Get full text
Article -
370
A critical review on phytochemical profile and health promoting effects of mung bean (Vigna radiata)
Published 2018-03-01“…The various curative potential of mung bean provides successive preclinical outcomes in the field of drug discovery and this review strongly recommends that mung bean is an excellent nutritive legume, which modulates or prevents chronic degenerative diseases. …”
Get full text
Article -
371
A combination of topical and systemic administration of brimonidine is neuroprotective in the murine optic nerve crush model.
Published 2024-01-01“…<h4>Conclusions</h4>brimonidine eye drops supplemented with IP brimonidine injections improved RGC survival in a preclinical model of ONC.…”
Get full text
Article -
372
MCF-DTI: Multi-Scale Convolutional Local–Global Feature Fusion for Drug–Target Interaction Prediction
Published 2025-01-01“…Our case study demonstrates that our model effectively validated several known drug–target relationships in lung cancer and predicted the therapeutic potential of certain preclinical compounds in treating lung cancer. These findings contribute valuable insights for subsequent drug repurposing efforts and novel drug development.…”
Get full text
Article -
373
Mitotic Kinases and p53 Signaling
Published 2012-01-01“…Because of their importance during mitosis and the relevance to cancer, mitotic kinase signaling has been extensively studied over the past few decades and, as a result, several mitotic kinase inhibitors have been developed. Despite promising preclinical results, targeting mitotic kinases for cancer therapy faces numerous challenges, including safety and patient selection issues. …”
Get full text
Article -
374
The Nicotinic Acetylcholine Receptor as a Target for Antidepressant Drug Development
Published 2012-01-01“…These drugs probably exert their effects via antagonism at α4β2 nAChRs, and strong preclinical data support the antidepressant efficacy of both classes when used in conjunction with other primary antidepressants (e.g., monoamine reuptake inhibitors). …”
Get full text
Article -
375
The Role of Organelle Stresses in Diabetes Mellitus and Obesity: Implication for Treatment
Published 2015-01-01“…ROS scavengers, chemical chaperones, and autophagy activators have demonstrated promising effects for the treatment of insulin resistance and diabetes in preclinical models. Further results from clinical trials are eagerly awaited.…”
Get full text
Article -
376
Gliclazide protects ionizing radiation-induced intestinal injury in mice by inhibiting oxidative stress and caspase-3
Published 2024-12-01“…The administration of GLZ resulted in a marked decrease in caspase-3 immunoreactivity in the ileum of irradiated mice. This preclinical study exhibited that GLZ has a radioprotective effect against intestinal injury by inhibiting oxidative stress and apoptosis.…”
Get full text
Article -
377
A Comprehensive Review of Ethnomedicinal Uses, Phytochemistry, Pharmacology, and Toxicity of Prunus africana (Hook. F.) Kalkman from Africa
Published 2024-01-01“…This review offers a comprehensive compilation of ethnomedicinal applications, phytochemical composition, pharmacological effects, and toxicity assessments of P. africana, serving as a foundation for future preclinical and clinical investigations. By understanding its traditional uses and chemical constituents, researchers can target specific medical conditions with greater precision, potentially expediting the development of safe and effective pharmaceuticals. …”
Get full text
Article -
378
Stem Cells in the Treatment of Neuropathic Pain: Research Progress of Mechanism
Published 2020-01-01“…Recently, research on the treatment of NP by stem cells is increasing and promising results have been achieved in preclinical research. In this review, we briefly introduce the neuropathic pain, the current treatment strategy, and the development of stem cell therapy, and we collected the experimental and clinical trial articles of many kinds of stem cells in the treatment of neuropathic pain from the past ten years. …”
Get full text
Article -
379
Chimerism-Based Experimental Models for Tolerance Induction in Vascularized Composite Allografts: Cleveland Clinic Research Experience
Published 2013-01-01“…The preclinical experimental models of vascularized composite allografts (VCAs) have been rapidly developed for the assessment of immunomodulatory protocols for clinical application. …”
Get full text
Article -
380
Immunological Regulation of Fibrosis During Heart Failure: It Takes Two to Tango
Published 2025-01-01“…The aims of this review are to (i) briefly summarize the role of key immune cells that regulate wound healing during MI and fibrosis during LV remodeling; (ii) underscore phenotypic diversities in immune cells and their subsets to underscore their role in regulating fibrotic responses, and, last but not the least, (iii) highlight gaps in our understanding that restrict the translation of immuno-modulatory therapies from the preclinical models to heart failure patients.…”
Get full text
Article